TITLE

"Susceptible" smokers?

AUTHOR(S)
Anthonisen, N. R.
PUB. DATE
November 2006
SOURCE
Thorax;Nov2006, Vol. 61 Issue 11, p924
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article comments on the findings of the study on the susceptibility of cigarette smokers to chronic obstructive pulmonary disease (COPD) in the Copenhagen City Heart Study in Copenhagen, Denmark. Results showed that over 24 percent of smokers who underwent spirometric tests have COPD, while less than five percent of nonsmokers have COPD. The author agrees with the conclusion that smokers establish airways obstruction while they live long and continue to smoke.
ACCESSION #
23259064

 

Related Articles

  • Use office spirometry to screen smokers for COPD.  // Geriatrics;Jul2000, Vol. 55 Issue 7, p28 

    States that office spirometry should be used to screen smokers for chronic obstructive pulmonary disease (COPD), according to the recommendations published by the National Lung Health Education Program. Importance of early detection of COPD; Benefits of using office spirometers; Why most...

  • Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Shahab, L.; Jarvis, M. J.; Britton, J.; West, R. // Thorax;Dec2006, Vol. 61 Issue 12, p1043 

    Background: Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death worldwide. It is caused primarily by cigarette smoking. Given its importance, it is remarkable that reliable national prevalence data are lacking for most countries. This study provides estimates of...

  • Bronchial hyperresponsiveness and the development of asthma and COPD in asymptomatic individuals: SAPALDIA Cohort Study. Brutsche, M. H.; Downs, S. H.; Schindler, C.; Gerbase, M. W.; Schwartz, J.; Frey, M.; Russi, E. W.; Ackermann-Liebrich, U.; Leuenberger, P. // Thorax;Aug2006, Vol. 61 Issue 8, p671 

    Background: Bronchial hyperrespansiveness (BHR) is a common feature of asthma. However, BHR is also present in asymptomatic individuals and its clinical and prognostic significance is unclear. We hypothesised that BHR might play a role in the development of chronic obstructive pulmonary disease...

  • Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Hanania, Nicola A.; Sharafkhaneh, Amir; Celli, Bartolome; Decramer, Marc; Lystig, Ted; Kesten, Steven; Tashkin, Donald // Respiratory Research;Jan2011, Vol. 12 Issue 1, p1 

    Background: Debate continues as to whether acute bronchodilator responsiveness (BDR) predicts long-term outcomes in COPD. Furthermore, there is no consensus on a threshold for BDR. Methods: At baseline and during the 4-year Understanding Potential Long-term Improvements in Function with...

  • COPD in Never Smokers. Kuritzky, Louis // Neurology Alert;Jul2011, Vol. 29 Issue 11, p13 

    The article focuses on research on the impact of chronic obstructive pulmonary disease (COPD) in never smokers conducted by B. Lamprecht and colleagues and published in a 2011 issue of "Chest."

  • From reduced smoking to quitting: improvements in COPD symptoms and lung function: a case report. Fagerström, Karl Olov // Nicotine & Tobacco Research;Feb2001, Vol. 3 Issue 1, p93 

    This case report describes a smoker with chronic obstructive pulmonary disease (COPD) who had given up on trying to stop smoking because of many failed attempts. The patient, a 55-year-old woman, was, however, interested in reducing smoking and harm. During a long reduction phase, aided by...

  • Chronic Obstructive Pulmonary Disease and Proteomics: A Match for Success? Alexandre, Bruno M.; Penque, Deborah // Journal of Allergy & Therapy;Special2012, Vol. 3 Issue S, Special section p1 

    Chronic obstructive pulmonary disease (COPD) is characterized by chronic airflow limitation that is not fully reversible even under bronchodilators effect, caused by a mixture of small airway disease and parenchymal destruction. COPD is a major cause of morbidity and mortality in adults, and it...

  • The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers. Rytila, Paula; Helin, Timo; Kinnula, Vuokko // Primary Care Respiratory Journal;Dec2008, Vol. 17 Issue 4, p232 

    Aims: COPD is an underdiagnosed disease. This study was undertaken to assess the value of microspirometry in detecting reduced FEV1 values in cigarette smokers i.e. subjects at high risk for COPD. Methods: A total of 611 smokers or ex-smokers with a smoking history >20 years and no...

  • Determinación de valores espirométricos en jóvenes fumadores y no fumadores. Muñoz-Pérez, María José; Palafox, Damián; Palafox, José; Vichido-Luna, Miguel Ángel; Espinosa-Villaseñor, Natalia; Rivas-Chávez, Adrián; Varela-Cabrera, José Alejandro; Soto-Vega, Elena // Medicina Interna de Mexico;nov/dic2013, Vol. 29 Issue 6, p553 

    Background: COPD is a condition that affects millions of people. Standard for diagnosis of this disease is spirometry. Many young smokers at an early stage of COPD could be detected by spirometry. Objective: To identify by means of spirometry young smokers with airflow. material and methods: An...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics